TAMMY TUNIS: Open Payments
NPI 1447809926 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 39 payments from 13 companies in 2025. Trend: 2023 $457 · 2024 $1,158 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $268 |
| Amgen Inc. | 9 | $142 |
| Radius Health, Inc. | 4 | $109 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Janssen Biotech, Inc. | 3 | $65 |
| Novo Nordisk Inc | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Boston Scientific Corporation | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
Products named: BOTOX, Tymlos, EVENITY, RINVOQ, TREMFYA, TRELEGY ELLIPTA, OTEZLA, CREON.
Industry payments across AZ — which companies pay providers there.
